Medications Development for Cannabis-Related Disorders (R01)
Published Date
Agency
CFDA
93.279
Contact Information
Deborah Wertz, 301-443-6710; dwertz@nida.nih.gov
Deadline
Department
Eligiblity
State, local and tribal governments, school districts, public and Indian housing authorities, tribal organizations, institutions of higher education, and nonprofit and for-profit organizations
Guide Page Reference
None
More Information
Program Area
Programe Purpose
To support research studies that focus on the identification, preclinical and clinical evaluation of medications that can be safe and effective for the treatment of cannabis-use and -induced disorders, as well as their medical and psychiatric consequences
